AVSD in review
By : dr. Sh.A.O.Bawazir
General pediatric resident
R3
Objectives:-
Introduction and Types
The pathophysiology
perioperative management issues
potential complications
expected early postoperative outcomes
Introduction
• AVSDs
• atrioventricular valves ( common valve ) (pathognomonic)
• atrial septum deficit
• the ventricular septum deficit
• 4-5% of all congenital heart deficit
• Prevalence 0.3- 0.4/1000 living birth
Introduction
• Common associated with Down syndrome 50-60% (44% CHD & 39%
AVSD)
• Around 50% isolated with no genetic abnormality
• (M : F) 1.57
• Recurrent risk :
• in first degree 3-4% if have on affected child
• 10% if mother affected
• No risk if father affected
Types
Avsd   picu
pathophysiology
Perioperative
management issues
perioperative management issues
• Perioperative morbidity and mortality for repair of AVSD improved
over time secondary to:
• improved screening methods
• early repair
• better surgical techniques
• enhanced understanding of postoperative complications.
• Infants usually presented with systemic pulmonary artery pressures
and congestive heart failure required anti congestive medication to
prevent Eisenmenger heart
• Severe CHF in small infants (treated palliatively AP band) care higher
Mortality .
preoperative management issues
• Optimal management requires a multidisciplinary team approach
• Optimal time for repair CAVSD between (3 - 6 m) age.
• Optimal Weight is 4kg and more
• Deciding how to manage this complex group of patients requires assessment of
clinical imaging and hemodynamic data .
• Ventricular volumes determined by three dimensional ECHO
• MRI scans may guide therapy with the ability to recruit ventricles with volume as low as 15–
30 ml/m2.
1. Knowledge of the underlying lesion?
2. Evidence of long-term complications and other features that put children into a high-risk category?
3. General medical condition & Evidence of recent upper or lower respiratory tract infections?
4. Routine drug therapy and previous surgery ?
Key features in preoperative assessment
Key features in preoperative
assessment
6.Venous access
7.Basic lab. Study and imaging ?
8. Sedative premedication: commonly used to avoid distress, minimize oxygen
consumption, and may also reduce the amount of induction agent so minimizing
reductions in SVR
9. Anesthesiologist assessment
Special consideration for down syndrome
• high incidence of extracardiac anomalies
• cohort of patients is known to develop early severe pulmonary
hypertension (PH) and pulmonary vascular obstructive disease
(PVOD)
• Particularly difficult sedition & anesthesia because of abnormal
concentrations of opioid receptors in the cerebral cortex, nociception,
anxiety levels, and neurotransmission,
• Preoperative screening for thyroid function is essential
• Vascular access continues to be challenging secondary to
abnormalities of the vasculature, skin, and subcutaneous fat.
Intra operative
Intra operative
Detail of significant :
• ASA
• CPB time
• Cross clamp time
• Blood transfusion
• End of OP rhythm (NSR)
• Medication : Inotrope used and doses ,Heparin
• TEE – ECHO for any residual
Intra operative
the modified single-patch technique
pledgeted sutures
Pulmonary artery (PA) banding
• no longer used in the elective routine repair
of complete AVSD in favor of a 1 stage repair.
• 5%–10% of patients coming for AVSD surgery
will require PA banding
• Indication of PA band:
• cases with pulmonary over circulation (AVSD)
Low weight and extremely septic infant
• patient with a contraindication for CPB, eg.,CNS
and recent intracranial bleed, necessitate
palliative procedure
Single ventricle physiologies (uAVSD)
GOALS :
• Unobstructed systemic blood flow
• Unobstructed pulmonary venous return
• Limited pulmonary blood flow
• Undistorted pulmonary arteries (PVR)
• Minimal AVV regurgitation
“Children with single-ventricle anatomy will ultimately undergo some
variation of the Fontan operation as their final surgical palliation”
BT - shunt
• the Blalock–Taussig shunt:
• is a surgical procedure used to increase
pulmonary blood flow for palliation in
duct dependent cyanotic heart defects
as patient with hypoplastic left ventricle
Glenn system
• Aim too separate the systemic and pulmonary circuits,
resulting in normal or near normal oxygen saturation.
• After these procedures, the single ventricle ejects blood
only to the systemic circuit, with pulmonary blood flow
derived by “passive flow” into the pulmonary vascular bed
at the expense of higher central venous pressure.
• connections improve cyanosis and minimize ventricular
work, the elevated PVR in the neonate precludes their use
until approximately 3 months of age.
• At 2 to 5 years of age,
• The inferior vena cava is connected to the pulmonary artery.
directed the venous return passively to the pulmonary arteries.
• A small communication is often left in the baffle to allow some residual right-to-left
mixing, which improves perioperative hemodynamics.
This communication (fenestration) often closes spontaneously or can be closed
percutaneously some time later
• increasing the systemic oxygen saturation to >95%
postoperative period
Postoperative Evaluation by ICU physician:
• Review of patient’s underlying cardiac defect(s),
• history of prior interventions,& preOp pathophysiology & clinical status
• Review of anesthesia record & operative note
• Verifications :
• current medication dosages
• ventilator settings
• IV fluid rates
• Physical examinations focusing (CVS.RESP)
• Interpretation of data from bedside monitoring & initial lab testing
• Documentation in the medical record of physical exam & lab findings,
• evaluation of the adequacy of the procedure,
• plans for the first postop night
postoperative issue (high light) :
-The issue (patients with a complete AVSD )may have a reactive
pulmonary arterial bed .
• These patients may benefit from a 1- to 3-day period of sedation
careful ventilator management
to minimize the chances of a pulmonary hypertensive crisis,
HOW?
In the current era with most patients undergoing repair at
approximately 4 months old, pulmonary hypertension is usually not a
major problem in the postoperative period
low cardiac output syndrome (LCOS)
• typically occurs 6 to 18 hours after cardiopulmonary bypass (CPB)
surgery
• Prevent by using inotropic support
• monitor cardiac output postoperatively
• Lactate
• physical examination
• intermittent or continuous venous saturation
• ECHO
• Temp. (peripheral and core )
• Eighty-five respondents (85/98 = 87%) answered this question and indicated
increasing either milrinone (42%) or adrenaline/epinephrine (36%) when cardiac
output is worsening
• If this treatment fails, then in most of the cases adrenaline/epinephrine (40%) will
be added as the second drug of choice.
Avsd   picu
sedative and analgesic
• Selection and appropriate use of sedative and analgesic medications
remain challenging in all patients in ICU, but postoperative cardiac
patients present some unique challenges.
• Two alternatives to opiates and benzodiazepines have evolved that
show promising results and improved profiles of side effects:
• dexmedetomidine
• caudal anesthesia (promising new technique)
caudal anesthesia
• blunt the stress response to CPB
• resulting in:
- decreased intraoperative narcotic
requirements,
- no impact on hemodynamics.
- Caudal anesthesia may facilitate early
extubation.
suture disruption
-they should be carefully assessed for suture disruption
• Why?
• leading to left or right atrioventricular valve insufficiency and/or
recurrent ventricular or atrial level shunting.
potential complications
potential complications
• Children with AVSD (complete AVSD) have a significant morbidity and
mortality 20%
• postoperative left atrioventricular valve regurgitation (LAVV)
• residual intracardiac shunts
• postoperative pulmonary hypertension
• various life-threatening cardiac arrhythmias
• left ventricular outflow tract obstruction.
expected early
postoperative outcomes
Shunt Lesions Part I: Patent Ductus Arteriosus,
Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect
Carl L. Backer, MD1,2; Osama Eltayeb, MD1,2; Michael C. Mongé, MD1,2; Mjaye L. Mazwi MD3,4;
John M. Costello, MD, MPH3,4
• Complete AVSD:
• Median age at repair was 4 months.
• one early mortality (4 mo postoperatively).
• There were no patients with heart block requiring a pacemaker.
• The median hospital stay was 9 days.
• Two patients ultimately underwent reoperation for left ventricular outflow tract
obstruction.
• Three patients underwent reoperation for left atrioventricular valve insufficiency.
Congenital Heart Disease
Shunt Lesions Part I: Patent Ductus Arteriosus,
Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect
Carl L. Backer, MD1,2; Osama Eltayeb, MD1,2; Michael C. Mongé, MD1,2; Mjaye L. Mazwi MD3,4;
John M. Costello, MD, MPH3,4
• partial AVSD:
• Between 1990 and 2015, 89 children underwent repair
• median age of 1.6 years.
• There was no operative mortality.
• 2 patients required pacemakers
• 3 patients underwent reoperation for left atrioventricular valve
insufficiency,
• 6 patient for subaortic stenosis.
Congenital Heart Disease
• Major complications occurred 9.8%
• permanent pacemaker implantation in 2.7%.
• Overall mortality was 3%.
• associated with higher mortality, longer postoperative length of stay in (ICU)
and higher incidence of major complications.
• Weight <3.5 kg
• age <2.5 months
• Surprisingly, children with Down's syndrome had lower morbidity and
mortality than other children, and their duration of ICU stay was similar.
Outcomes of repair of complete atrioventricular septal
defect in the current era.
Xie O, Brizard CP, d'Udekem Y, Galati JC, Kelly A, Yong MS, Weintraub RG, Konstantinov IE
Eur J Cardiothorac Surg. 2014 Apr; 45(4):610-7.
Royal children's Hospital Melbourne
• Age >6 months at repair was associated with higher rates of
reoperation
• operating at age <6 months was associated with longer ICU stay.
• Moderate AVV regurgitation at discharge was a risk factor for
reoperation.
• Down's syndrome present in 75% of patients was not at higher risk
At the end
• The natural history of complete AVSD includes:
• premature death due to complications of congestive heart failure and
or PA hypertension.
• Repair during infancy is recommended for all children.
• The age at elective repair 3–6 months at most centers today.
• Early repair minimizes the risk of premature death or pulmonary
vascular obstructive disease.
• CAVSD is frequently associated with Down's syndrome.
Thank you

More Related Content

PPT
Synopses in vsd
PPTX
ECHOCARDIOGRAPHY IN CARDIAC TAMPONADE
PPT
Natural history of common congenital heart diseases
PPTX
Echo in Pericardial Diseases
PPT
Spontaneous coronary artery dissection
PPT
Congenital cyanotic heart disease approach
PPTX
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
PPT
Cardiac tumors
Synopses in vsd
ECHOCARDIOGRAPHY IN CARDIAC TAMPONADE
Natural history of common congenital heart diseases
Echo in Pericardial Diseases
Spontaneous coronary artery dissection
Congenital cyanotic heart disease approach
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
Cardiac tumors

What's hot (20)

PPTX
Speckle Tracking Echocardiography
PPTX
Left main pci
PDF
Aorto pulmonary window may 2021
PPTX
Pulmonary arterial hypertension in congenital heart disease
PPTX
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
PPTX
Cardiac tumors
PPT
single ventricle physiology
PPTX
Ffr guided coronarY intervention
PPTX
interpretation of hemodynamic data
PPTX
Percutaneous mitral valve interventions for MR
PPTX
M mode lecture
PPTX
Brugada syndrome
PPTX
OPCAB.pptx
PDF
Cardiac Interventions in Pediatric Cardiology: The Future
PPTX
HEMODYNAMICS & NATURAL HISTORY OF PS.pptx
PPT
Guidelines for intraaortic balloon counterpulsation
PPTX
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
PPT
Ivc guided fluid management in the icu
PPTX
Critical chest radiographs cant miss
PPTX
Vsd device closure
Speckle Tracking Echocardiography
Left main pci
Aorto pulmonary window may 2021
Pulmonary arterial hypertension in congenital heart disease
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
Cardiac tumors
single ventricle physiology
Ffr guided coronarY intervention
interpretation of hemodynamic data
Percutaneous mitral valve interventions for MR
M mode lecture
Brugada syndrome
OPCAB.pptx
Cardiac Interventions in Pediatric Cardiology: The Future
HEMODYNAMICS & NATURAL HISTORY OF PS.pptx
Guidelines for intraaortic balloon counterpulsation
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
Ivc guided fluid management in the icu
Critical chest radiographs cant miss
Vsd device closure
Ad

Similar to Avsd picu (20)

PPT
Approach to cardiac surgical diseases
PPT
Carotid+lecture+final[1].ppt
PPT
Anesthesia for Carotid Surgery
PDF
PICU cardiac guide - PICUDoctor.org
PPTX
Eisenmenger syndrome
PPTX
5_6125448697896502769.pptx
PPTX
IC TT 01.pptx
PPTX
role of surgeons in critical care and icu.pptx
PPT
Cardiac Transplantation
PPTX
Pulmonary embolism
PPTX
SEMINAR CARDIAC TRANSPLANT.pptx
PPTX
Interventional management of out hospital cardiac arrest
PPTX
Preoperative evaluation and management
PPTX
Heart diseases in pregnancy.pptx
PPTX
Tom Bleck - Subarachnoid Hemorrhage: What Matters?
PPTX
approach to non traumatic shock ppt (1).pptx
PPTX
Journal club may 2016
PPTX
Peripartum Cardiomyopathy presentation and management.pptx
PPTX
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Approach to cardiac surgical diseases
Carotid+lecture+final[1].ppt
Anesthesia for Carotid Surgery
PICU cardiac guide - PICUDoctor.org
Eisenmenger syndrome
5_6125448697896502769.pptx
IC TT 01.pptx
role of surgeons in critical care and icu.pptx
Cardiac Transplantation
Pulmonary embolism
SEMINAR CARDIAC TRANSPLANT.pptx
Interventional management of out hospital cardiac arrest
Preoperative evaluation and management
Heart diseases in pregnancy.pptx
Tom Bleck - Subarachnoid Hemorrhage: What Matters?
approach to non traumatic shock ppt (1).pptx
Journal club may 2016
Peripartum Cardiomyopathy presentation and management.pptx
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Ad

Recently uploaded (20)

PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
Assessment of fetal wellbeing for nurses.
PPTX
Hypertensive disorders in pregnancy.pptx
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PPTX
Primary Tuberculous Infection/Disease by Dr Vahyala Zira Kumanda
PPTX
Wheat allergies and Disease in gastroenterology
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
Post Op complications in general surgery
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
Assessment of fetal wellbeing for nurses.
Hypertensive disorders in pregnancy.pptx
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
nephrology MRCP - Member of Royal College of Physicians ppt
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
Primary Tuberculous Infection/Disease by Dr Vahyala Zira Kumanda
Wheat allergies and Disease in gastroenterology
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Post Op complications in general surgery
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Forensic Psychology and Its Impact on the Legal System.pdf
The_EHRA_Book_of_Interventional Electrophysiology.pdf
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
OSCE SERIES - Set 7 ( Questions & Answers ).pdf

Avsd picu

  • 1. AVSD in review By : dr. Sh.A.O.Bawazir General pediatric resident R3
  • 2. Objectives:- Introduction and Types The pathophysiology perioperative management issues potential complications expected early postoperative outcomes
  • 3. Introduction • AVSDs • atrioventricular valves ( common valve ) (pathognomonic) • atrial septum deficit • the ventricular septum deficit • 4-5% of all congenital heart deficit • Prevalence 0.3- 0.4/1000 living birth
  • 4. Introduction • Common associated with Down syndrome 50-60% (44% CHD & 39% AVSD) • Around 50% isolated with no genetic abnormality • (M : F) 1.57 • Recurrent risk : • in first degree 3-4% if have on affected child • 10% if mother affected • No risk if father affected
  • 9. perioperative management issues • Perioperative morbidity and mortality for repair of AVSD improved over time secondary to: • improved screening methods • early repair • better surgical techniques • enhanced understanding of postoperative complications. • Infants usually presented with systemic pulmonary artery pressures and congestive heart failure required anti congestive medication to prevent Eisenmenger heart • Severe CHF in small infants (treated palliatively AP band) care higher Mortality .
  • 10. preoperative management issues • Optimal management requires a multidisciplinary team approach • Optimal time for repair CAVSD between (3 - 6 m) age. • Optimal Weight is 4kg and more • Deciding how to manage this complex group of patients requires assessment of clinical imaging and hemodynamic data . • Ventricular volumes determined by three dimensional ECHO • MRI scans may guide therapy with the ability to recruit ventricles with volume as low as 15– 30 ml/m2.
  • 11. 1. Knowledge of the underlying lesion? 2. Evidence of long-term complications and other features that put children into a high-risk category? 3. General medical condition & Evidence of recent upper or lower respiratory tract infections? 4. Routine drug therapy and previous surgery ? Key features in preoperative assessment
  • 12. Key features in preoperative assessment 6.Venous access 7.Basic lab. Study and imaging ? 8. Sedative premedication: commonly used to avoid distress, minimize oxygen consumption, and may also reduce the amount of induction agent so minimizing reductions in SVR 9. Anesthesiologist assessment
  • 13. Special consideration for down syndrome • high incidence of extracardiac anomalies • cohort of patients is known to develop early severe pulmonary hypertension (PH) and pulmonary vascular obstructive disease (PVOD) • Particularly difficult sedition & anesthesia because of abnormal concentrations of opioid receptors in the cerebral cortex, nociception, anxiety levels, and neurotransmission, • Preoperative screening for thyroid function is essential • Vascular access continues to be challenging secondary to abnormalities of the vasculature, skin, and subcutaneous fat.
  • 15. Intra operative Detail of significant : • ASA • CPB time • Cross clamp time • Blood transfusion • End of OP rhythm (NSR) • Medication : Inotrope used and doses ,Heparin • TEE – ECHO for any residual
  • 16. Intra operative the modified single-patch technique pledgeted sutures
  • 17. Pulmonary artery (PA) banding • no longer used in the elective routine repair of complete AVSD in favor of a 1 stage repair. • 5%–10% of patients coming for AVSD surgery will require PA banding • Indication of PA band: • cases with pulmonary over circulation (AVSD) Low weight and extremely septic infant • patient with a contraindication for CPB, eg.,CNS and recent intracranial bleed, necessitate palliative procedure
  • 18. Single ventricle physiologies (uAVSD) GOALS : • Unobstructed systemic blood flow • Unobstructed pulmonary venous return • Limited pulmonary blood flow • Undistorted pulmonary arteries (PVR) • Minimal AVV regurgitation “Children with single-ventricle anatomy will ultimately undergo some variation of the Fontan operation as their final surgical palliation”
  • 19. BT - shunt • the Blalock–Taussig shunt: • is a surgical procedure used to increase pulmonary blood flow for palliation in duct dependent cyanotic heart defects as patient with hypoplastic left ventricle
  • 20. Glenn system • Aim too separate the systemic and pulmonary circuits, resulting in normal or near normal oxygen saturation. • After these procedures, the single ventricle ejects blood only to the systemic circuit, with pulmonary blood flow derived by “passive flow” into the pulmonary vascular bed at the expense of higher central venous pressure. • connections improve cyanosis and minimize ventricular work, the elevated PVR in the neonate precludes their use until approximately 3 months of age.
  • 21. • At 2 to 5 years of age, • The inferior vena cava is connected to the pulmonary artery. directed the venous return passively to the pulmonary arteries. • A small communication is often left in the baffle to allow some residual right-to-left mixing, which improves perioperative hemodynamics. This communication (fenestration) often closes spontaneously or can be closed percutaneously some time later • increasing the systemic oxygen saturation to >95%
  • 23. Postoperative Evaluation by ICU physician: • Review of patient’s underlying cardiac defect(s), • history of prior interventions,& preOp pathophysiology & clinical status • Review of anesthesia record & operative note • Verifications : • current medication dosages • ventilator settings • IV fluid rates • Physical examinations focusing (CVS.RESP) • Interpretation of data from bedside monitoring & initial lab testing • Documentation in the medical record of physical exam & lab findings, • evaluation of the adequacy of the procedure, • plans for the first postop night
  • 24. postoperative issue (high light) : -The issue (patients with a complete AVSD )may have a reactive pulmonary arterial bed . • These patients may benefit from a 1- to 3-day period of sedation careful ventilator management to minimize the chances of a pulmonary hypertensive crisis, HOW? In the current era with most patients undergoing repair at approximately 4 months old, pulmonary hypertension is usually not a major problem in the postoperative period
  • 25. low cardiac output syndrome (LCOS) • typically occurs 6 to 18 hours after cardiopulmonary bypass (CPB) surgery • Prevent by using inotropic support • monitor cardiac output postoperatively • Lactate • physical examination • intermittent or continuous venous saturation • ECHO • Temp. (peripheral and core )
  • 26. • Eighty-five respondents (85/98 = 87%) answered this question and indicated increasing either milrinone (42%) or adrenaline/epinephrine (36%) when cardiac output is worsening • If this treatment fails, then in most of the cases adrenaline/epinephrine (40%) will be added as the second drug of choice.
  • 28. sedative and analgesic • Selection and appropriate use of sedative and analgesic medications remain challenging in all patients in ICU, but postoperative cardiac patients present some unique challenges. • Two alternatives to opiates and benzodiazepines have evolved that show promising results and improved profiles of side effects: • dexmedetomidine • caudal anesthesia (promising new technique)
  • 29. caudal anesthesia • blunt the stress response to CPB • resulting in: - decreased intraoperative narcotic requirements, - no impact on hemodynamics. - Caudal anesthesia may facilitate early extubation.
  • 30. suture disruption -they should be carefully assessed for suture disruption • Why? • leading to left or right atrioventricular valve insufficiency and/or recurrent ventricular or atrial level shunting.
  • 32. potential complications • Children with AVSD (complete AVSD) have a significant morbidity and mortality 20% • postoperative left atrioventricular valve regurgitation (LAVV) • residual intracardiac shunts • postoperative pulmonary hypertension • various life-threatening cardiac arrhythmias • left ventricular outflow tract obstruction.
  • 34. Shunt Lesions Part I: Patent Ductus Arteriosus, Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect Carl L. Backer, MD1,2; Osama Eltayeb, MD1,2; Michael C. Mongé, MD1,2; Mjaye L. Mazwi MD3,4; John M. Costello, MD, MPH3,4 • Complete AVSD: • Median age at repair was 4 months. • one early mortality (4 mo postoperatively). • There were no patients with heart block requiring a pacemaker. • The median hospital stay was 9 days. • Two patients ultimately underwent reoperation for left ventricular outflow tract obstruction. • Three patients underwent reoperation for left atrioventricular valve insufficiency. Congenital Heart Disease
  • 35. Shunt Lesions Part I: Patent Ductus Arteriosus, Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect Carl L. Backer, MD1,2; Osama Eltayeb, MD1,2; Michael C. Mongé, MD1,2; Mjaye L. Mazwi MD3,4; John M. Costello, MD, MPH3,4 • partial AVSD: • Between 1990 and 2015, 89 children underwent repair • median age of 1.6 years. • There was no operative mortality. • 2 patients required pacemakers • 3 patients underwent reoperation for left atrioventricular valve insufficiency, • 6 patient for subaortic stenosis. Congenital Heart Disease
  • 36. • Major complications occurred 9.8% • permanent pacemaker implantation in 2.7%. • Overall mortality was 3%. • associated with higher mortality, longer postoperative length of stay in (ICU) and higher incidence of major complications. • Weight <3.5 kg • age <2.5 months • Surprisingly, children with Down's syndrome had lower morbidity and mortality than other children, and their duration of ICU stay was similar.
  • 37. Outcomes of repair of complete atrioventricular septal defect in the current era. Xie O, Brizard CP, d'Udekem Y, Galati JC, Kelly A, Yong MS, Weintraub RG, Konstantinov IE Eur J Cardiothorac Surg. 2014 Apr; 45(4):610-7. Royal children's Hospital Melbourne • Age >6 months at repair was associated with higher rates of reoperation • operating at age <6 months was associated with longer ICU stay. • Moderate AVV regurgitation at discharge was a risk factor for reoperation. • Down's syndrome present in 75% of patients was not at higher risk
  • 38. At the end • The natural history of complete AVSD includes: • premature death due to complications of congestive heart failure and or PA hypertension. • Repair during infancy is recommended for all children. • The age at elective repair 3–6 months at most centers today. • Early repair minimizes the risk of premature death or pulmonary vascular obstructive disease. • CAVSD is frequently associated with Down's syndrome.

Editor's Notes

  • #7: UNPALANCED AVSD, represent 10%–15% of all AVSD. This defect is characterized by underdevelopment of one of the ventricles and varying degrees of malalignment of the common AV valve, over the hypoplastic ventricle and associated hypoplasia of the outflow valve related to decreased flow. Management strategy includes single ventricle (SV) palliation, and primary or staged biventricular SV palliation, and primary or staged biventricular repair. More recently, biventricular conversion from SV palliation has been advocated, particularly in patients with trisomy 21 and heterotaxy, who tolerate SV palliation poorly. Staged biventricular recruitment has also been advocated for complete biventricular repair.
  • #8: -result in a left-toright intracardiac shunt --- increased pulmonary blood flow. ASDs - volume overload of the right ventricle---uncorrected may  lead to right heart failure and atrial arrhythmias (at the ventricular or great vessel level )Vsd  left-to-right shunts -- volume load on the left ventricle. If large ventricular or great vessel left-to-right shunts  the substantial increase in pulmonary venous return - increase in left ventricular end-diastolic pressure and pulmonary venous hypertension - resulting in symptoms of congestive heart failure, - S&S include failure to thrive, feeding difficulties, and diaphoresis. Common signs are tachypnea, tachycardia, and hepatomegaly. If unrestrictive and left untreated, all of these left-to-right shunts can - irreversible pulmonary vascular obstructive disease. The change in the ratio of systemic-to-pulmonary vascular resistance over time as a result of pulmonary vascular obstructive changes reverses the direction of the shunt, making it right to left. The patient becomes cyanotic and develops what is called “Eisenmenger syndrome patients with an ASD will have a fixed split second heart sound and may have a systolic murmur of physiologic pulmonary stenosis
  • #10: early infancy conventionally carried greater morbidity and mortality than repair performed later in life however improved surgical techniques myocardial protection, and postoperative care has led to a progressive reduction in operative mortality to <3%
  • #11: :combining the disciplines of cardiology, cardiac surgery, cardiacanesthesia, neonatology, intensive care, and nursing
  • #15: high incidence of extracardiac anomalies including abnormalities of the CNS, hypotonia, seizures, gut abnormalities, thyroid disorders, and airway abnormalities such as tracheal stenosis and laryngotracheomalacia, also there may be sedation issues, pulmonary arterial hypertension, and vascular access concerns, higher right-sided cardiac pressures and pulmonary vascular resistanc cohort of patients is known to develop early severe pulmonary hypertension (PH) and pulmonary vascular obstructive disease (PVOD); the pathophysiological mechanisms underlying the development of these complications are yet to be determined -Preoperative screening for thyroid function is essential, as hypothyroidism has been linked to decreased myocardial contractility and cardiac output
  • #19: .
  • #20: Indications for early shunt procedure:  Cyanosis secondary to inadequate pulmonary blood flow after neonatal palliation Congestive heart failure from an excessive volume load caused by severe atrioventricular valve regurgitation or by an elevated Qp:Qs
  • #22: Factors that increase PVR: -­‐Hypoxia -­‐Hypercarbia -­‐HyperinflaEon -­‐High hematocrit
  • #26: These patients may benefit from a 1- to 3-day period of sedation and careful ventilator management to minimize the chances of a pulmonary hypertensive crisis, which may be accomplished by maintaining a normal CO2/blood pH, and adequate sedation and oxygenation. Inhaled nitric oxide may be used to prevent or treat severe postoperative pulmonary hypertension. (In the current era with most patients undergoing repair at approximately 4 months old is usually in the postoperative period) reactive pulmonary arterial bed. (not a major problem ) .
  • #30: . Dexmedetomidine, an a2-adrenergic agonist, is a sedative with both anxiolytic and analgesic properties S.F hypo-BP, bradycardia found that dexmedetomidine may prevent or treat postoperative tachyarrhythmias, including junctional ectopic tachycardia, accelerated junctional rhythm, re-entrant supraventricular tachycardia, and ectopic atrial tachycardia
  • #34: -most commonly junctional ectopic tachycardia, followed by complete AV block, ventricular tachycardia and reentrant SVT and nonsustained SVT. At present, intravenous amiodarone is the recommended pharmacological treatment for most postoperative tachyarrhythmias to control the rate and restore AV synchrony. - -Pulmonary arterial hypertension: occurring in approximately 2% of children with hypertensive crisis occurring in 0.75%. This results in prolonged mechanical ventilation and increased the length of ICU stay and mortality of 20%. The incidence has reduced after the introduction of nitric oxide and earlier age at surgery. -Management would include pulmonary vasodilators (nitric oxide) sedation and analgesia, judicious use of PEEP to prevent atelectasis, and sodium bicarbonate to buffer acidosis. Rebound pulmonary hypertension after stopping nitric oxide requires sildenafil;